{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T23:25:32Z","timestamp":1791588332100,"version":"4.3.4"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2009,7,17]],"date-time":"2009-07-17T00:00:00Z","timestamp":1247788800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1007\/s00520-009-0688-1","type":"journal-article","created":{"date-parts":[[2009,7,15]],"date-time":"2009-07-15T22:10:35Z","timestamp":1247695835000},"page":"449-460","source":"Crossref","is-referenced-by-count":92,"title":["Osteotomy and primary wound closure in bisphosphonate-associated osteonecrosis of the jaw: a prospective clinical study with 12\u00a0months follow-up"],"prefix":"10.1007","volume":"18","author":[{"given":"Philipp","family":"Stockmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleftherios","family":"Vairaktaris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Falk","family":"Wehrhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Seiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Schwarz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd","family":"Spriewald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Friedrich-Wilhelm","family":"Neukam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emeka","family":"Nkenke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,7,17]]},"reference":[{"key":"688_CR1","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.joms.2006.11.003","volume":"65","author":"AAOMS","year":"2007","unstructured":"AAOMS (2007) American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws. J Oral Maxillofac Surg 65:369\u2013376","journal-title":"J Oral Maxillofac Surg"},{"key":"688_CR2","doi-asserted-by":"crossref","first-page":"971","DOI":"10.14219\/jada.archive.2007.0294","volume":"138","author":"MC Adornato","year":"2007","unstructured":"Adornato MC, Morcos I, Rozanski J (2007) The treatment of bisphosphonate-associated osteonecrosis of the jaws with bone resection and autologous platelet-derived growth factors. J Am Dent Assoc 138:971\u2013977","journal-title":"J Am Dent Assoc"},{"key":"688_CR3","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1097\/scs.0b013e31857261f","volume":"18","author":"A Agrillo","year":"2007","unstructured":"Agrillo A, Ungari C, Filiaci F, Priore P, Iannetti G (2007) Ozone therapy in the treatment of avascular bisphosphonate-related jaw osteonecrosis. J Craniofac Surg 18:1071\u20131075","journal-title":"J Craniofac Surg"},{"key":"688_CR4","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1080\/00016350600844360","volume":"64","author":"M Biasotto","year":"2006","unstructured":"Biasotto M, Chiandussi S, Dore F, Rinaldi A, Rizzardi C, Cavalli F, Di Lenarda R (2006) Clinical aspects and management of bisphosphonates-associated osteonecrosis of the jaws. Acta Odontol Scand 64:348\u2013354","journal-title":"Acta Odontol Scand"},{"key":"688_CR5","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/S0140-6736(96)07088-2","volume":"348","author":"DM Black","year":"1996","unstructured":"Black DM, Cummings SR, Karpf DB, Cauley JA, Thompson DE, Nevitt MC, Bauer DC, Genant HK, Haskell WL, Marcus R, Ott SM, Torner JC, Quandt SA, Reiss TF, Ensrud KE (1996) Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group. Lancet 348:1535\u20131541","journal-title":"Lancet"},{"key":"688_CR6","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.oraloncology.2007.11.012","volume":"44","author":"T Boonyapakorn","year":"2008","unstructured":"Boonyapakorn T, Schirmer I, Reichart PA, Sturm I, Massenkeil G (2008) Bisphosphonate-induced osteonecrosis of the jaws: prospective study of 80 patients with multiple myeloma and other malignancies. Oral Oncol 44:857\u2013869","journal-title":"Oral Oncol"},{"key":"688_CR7","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1834-7819.2003.tb00015.x","volume":"48","author":"GD Carter","year":"2003","unstructured":"Carter GD, Goss AN (2003) Bisphosphonates and avascular necrosis of the jaws. Aust Dent J 48:268","journal-title":"Aust Dent J"},{"key":"688_CR8","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1038\/sj.bjc.6604382","volume":"98","author":"RE Coleman","year":"2008","unstructured":"Coleman RE (2008) Risks and benefits of bisphosphonates. Br J Cancer 98:1736\u20131740","journal-title":"Br J Cancer"},{"key":"688_CR9","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.tripleo.2004.08.001","volume":"98","author":"MS Greenberg","year":"2004","unstructured":"Greenberg MS (2004) Intravenous bisphosphonates and osteonecrosis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 98:259\u2013260","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"688_CR10","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1016\/j.joms.2006.05.041","volume":"64","author":"KA Groetz","year":"2006","unstructured":"Groetz KA, Al-Nawas B (2006) Persisting alveolar sockets\u2014a radiologic symptom of BP-ONJ? J Oral Maxillofac Surg 64:1571\u20131572","journal-title":"J Oral Maxillofac Surg"},{"key":"688_CR11","first-page":"510","volume":"61","author":"KA Grotz","year":"2006","unstructured":"Grotz KA, Kreusch T (2006) Zahn\u00e4rztliche Betreuung von Patienten unter\/nach Bisphosphonat-Medikation (Wissenschaftliche Stellungnahme der DGZMK, AG Kieferchirurgie und DGMKG). Dtsch Zahn\u00e4rztl Z 61:510\u2013513","journal-title":"Dtsch Zahn\u00e4rztl Z"},{"key":"688_CR12","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.joms.2006.10.076","volume":"65","author":"RP Harper","year":"2007","unstructured":"Harper RP, Fung E (2007) Resolution of bisphosphonate-associated osteonecrosis of the mandible: possible application for intermittent low-dose parathyroid hormone [rhPTH(1-34)]. J Oral Maxillofac Surg 65:573\u2013580","journal-title":"J Oral Maxillofac Surg"},{"key":"688_CR13","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1359\/jbmr.080205","volume":"23","author":"AO Hoff","year":"2008","unstructured":"Hoff AO, Toth BB, Altundag K, Johnson MM, Warneke CL, Hu M, Nooka A, Sayegh G, Guarneri V, Desrouleaux K, Cui J, Adamus A, Gagel RF, Hortobagyi GN (2008) Frequency and risk factors associated with osteonecrosis of the jaw in cancer patients treated with intravenous bisphosphonates. J Bone Miner Res 23:826\u2013836","journal-title":"J Bone Miner Res"},{"key":"688_CR14","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.4065\/81.8.1100","volume":"81","author":"D Kademani","year":"2006","unstructured":"Kademani D, Koka S, Lacy MQ, Rajkumar SV (2006) Primary surgical therapy for osteonecrosis of the jaw secondary to bisphosphonate therapy. Mayo Clin Proc 81:1100\u20131103","journal-title":"Mayo Clin Proc"},{"key":"688_CR15","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1359\/jbmr.0707onj","volume":"22","author":"S Khosla","year":"2007","unstructured":"Khosla S, Burr D, Cauley J, Dempster DW, Ebeling PR, Felsenberg D, Gagel RF, Gilsanz V, Guise T, Koka S, McCauley LK, McGowan J, McKee MD, Mohla S, Pendrys DG, Raisz LG, Ruggiero SL, Shafer DM, Shum L, Silverman SL, Van Poznak CH, Watts N, Woo SB, Shane E (2007) Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res 22:1479\u20131491","journal-title":"J Bone Miner Res"},{"key":"688_CR16","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1600-0609.1981.tb00481.x","volume":"27","author":"HG Klingemann","year":"1981","unstructured":"Klingemann HG, Egbring R, Havemann K (1981) Incomplete fibrin formation and highly elevated Factor XIII activity in multiple myeloma. Scand J Haematol 27:253\u2013262","journal-title":"Scand J Haematol"},{"key":"688_CR17","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S1297-319X(01)00343-8","volume":"69","author":"V Lamboley","year":"2002","unstructured":"Lamboley V, Zabraniecki L, Sie P, Pourrat J, Fournie B (2002) Myeloma and monoclonal gammopathy of uncertain significance associated with acquired von Willebrand\u2019s syndrome. Seven new cases with a literature review. Jt Bone Spine 69:62\u201367","journal-title":"Jt Bone Spine"},{"key":"688_CR18","first-page":"2602","volume":"61","author":"MV Lee","year":"2001","unstructured":"Lee MV, Fong EM, Singer FR, Guenette RS (2001) Bisphosphonate treatment inhibits the growth of prostate cancer cells. Cancer Res 61:2602\u20132608","journal-title":"Cancer Res"},{"key":"688_CR19","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0278-2391(03)00720-1","volume":"61","author":"RE Marx","year":"2003","unstructured":"Marx RE (2003) Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg 61:1115\u20131117","journal-title":"J Oral Maxillofac Surg"},{"key":"688_CR20","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.joms.2005.07.010","volume":"63","author":"RE Marx","year":"2005","unstructured":"Marx RE, Sawatari Y, Fortin M, Broumand V (2005) Bisphosphonate-induced exposed bone (osteonecrosis\/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment. J Oral Maxillofac Surg 63:1567\u20131575","journal-title":"J Oral Maxillofac Surg"},{"key":"688_CR21","first-page":"109","volume":"77","author":"E Merigo","year":"2006","unstructured":"Merigo E, Manfredi M, Meleti M, Guidotti R, Ripasarti A, Zanzucchi E, D\u2019Aleo P, Corradi D, Corcione L, Sesenna E, Ferrari S, Poli T, Bonaninil M, Vescovi P (2006) Bone necrosis of the jaws associated with bisphosphonate treatment: a report of twenty-nine cases. Acta Biomed 77:109\u2013117","journal-title":"Acta Biomed"},{"key":"688_CR22","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.14219\/jada.archive.2005.0108","volume":"136","author":"CA Migliorati","year":"2005","unstructured":"Migliorati CA, Casiglia J, Epstein J, Jacobsen PL, Siegel MA, Woo SB (2005) Managing the care of patients with bisphosphonate-associated osteonecrosis: an American Academy of Oral Medicine position paper. J Am Dent Assoc 136:1658\u20131668","journal-title":"J Am Dent Assoc"},{"key":"688_CR23","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.tripleo.2007.01.008","volume":"104","author":"L Montebugnoli","year":"2007","unstructured":"Montebugnoli L, Felicetti L, Gissi DB, Pizzigallo A, Pelliccioni GA, Marchetti C (2007) Biphosphonate-associated osteonecrosis can be controlled by nonsurgical management. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 104:473\u2013477","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"688_CR24","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1034\/j.1600-0501.2001.120510.x","volume":"12","author":"E Nkenke","year":"2001","unstructured":"Nkenke E, Schultze-Mosgau S, Radespiel-Troger M, Kloss F, Neukam FW (2001) Morbidity of harvesting of chin grafts: a prospective study. Clin Oral Implants Res 12:495\u2013502","journal-title":"Clin Oral Implants Res"},{"key":"688_CR25","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.3324\/haematol.11096","volume":"92","author":"MT Petrucci","year":"2007","unstructured":"Petrucci MT, Gallucci C, Agrillo A, Mustazza MC, Foa R (2007) Role of ozone therapy in the treatment of osteonecrosis of the jaws in multiple myeloma patients. Haematologica 92:1289\u20131290","journal-title":"Haematologica"},{"key":"688_CR26","doi-asserted-by":"crossref","first-page":"73S","DOI":"10.1016\/S8756-3282(99)00070-8","volume":"24","author":"MJ Rogers","year":"1999","unstructured":"Rogers MJ, Frith JC, Luckman SP, Coxon FP, Benford HL, Monkkonen J, Auriola S, Chilton KM, Russell RG (1999) Molecular mechanisms of action of bisphosphonates. Bone 24:73S\u201379S","journal-title":"Bone"},{"key":"688_CR27","doi-asserted-by":"crossref","first-page":"3150","DOI":"10.1200\/JCO.2003.04.105","volume":"21","author":"LS Rosen","year":"2003","unstructured":"Rosen LS, Gordon D, Tchekmedyian S, Yanagihara R, Hirsh V, Krzakowski M, Pawlicki M, de Souza P, Zheng M, Urbanowitz G, Reitsma D, Seaman JJ (2003) Zoledronic acid versus placebo in the treatment of skeletal metastases in patients with lung cancer and other solid tumors: a phase III, double-blind, randomized trial\u2014the Zoledronic Acid Lung Cancer and Other Solid Tumors Study Group. J Clin Oncol 21:3150\u20133157","journal-title":"J Clin Oncol"},{"key":"688_CR28","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.joms.2004.02.004","volume":"62","author":"SL Ruggiero","year":"2004","unstructured":"Ruggiero SL, Mehrotra B, Rosenberg TJ, Engroff SL (2004) Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases. J Oral Maxillofac Surg 62:527\u2013534","journal-title":"J Oral Maxillofac Surg"},{"issue":"Suppl 2","key":"688_CR29","doi-asserted-by":"crossref","first-page":"S66","DOI":"10.1007\/PL00004164","volume":"9","author":"RG Russell","year":"1999","unstructured":"Russell RG, Croucher PI, Rogers MJ (1999) Bisphosphonates: pharmacology, mechanisms of action and clinical uses. Osteoporos Int 9(Suppl 2):S66\u2013S80","journal-title":"Osteoporos Int"},{"key":"688_CR30","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1601-0825.2007.01381.x","volume":"14","author":"J Sarin","year":"2008","unstructured":"Sarin J, Derossi SS, Akintoye SO (2008) Updates on bisphosphonates and potential pathobiology of bisphosphonate-induced jaw osteonecrosis. Oral Dis 14:277\u2013285","journal-title":"Oral Dis"},{"key":"688_CR31","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1054\/bjoc.1999.1131","volume":"82","author":"SG Senaratne","year":"2000","unstructured":"Senaratne SG, Pirianov G, Mansi JL, Arnett TR, Colston KW (2000) Bisphosphonates induce apoptosis in human breast cancer cell lines. Br J Cancer 82:1459\u20131468","journal-title":"Br J Cancer"},{"key":"688_CR32","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1532\/IJH97.06110","volume":"84","author":"K Shimura","year":"2006","unstructured":"Shimura K, Shimazaki C, Taniguchi K, Akamatsu S, Okamoto M, Uchida R, Nomura K, Inaba T, Horiike S, Kanamura N, Taniwaki M (2006) Hyperbaric oxygen in addition to antibiotic therapy is effective for bisphosphonate-induced osteonecrosis of the jaw in a patient with multiple myeloma. Int J Hematol 84:343\u2013345","journal-title":"Int J Hematol"},{"key":"688_CR33","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1046\/j.1365-2141.1997.2713086.x","volume":"98","author":"CM Shipman","year":"1997","unstructured":"Shipman CM, Rogers MJ, Apperley JF, Russell RG, Croucher PI (1997) Bisphosphonates induce apoptosis in human myeloma cell lines: a novel anti-tumour activity. Br J Haematol 98:665\u2013672","journal-title":"Br J Haematol"},{"key":"688_CR34","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/j.joms.2003.09.001","volume":"61","author":"P Tarassoff","year":"2003","unstructured":"Tarassoff P, Csermak K (2003) Avascular necrosis of the jaws: risk factors in metastatic cancer patients. J Oral Maxillofac Surg 61:1238\u20131239","journal-title":"J Oral Maxillofac Surg"},{"key":"688_CR35","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/CCO.0b013e32819f820b","volume":"19","author":"T Wyngaert Van den","year":"2007","unstructured":"Van den Wyngaert T, Huizing MT, Vermorken JB (2007) Osteonecrosis of the jaw related to the use of bisphosphonates. Curr Opin Oncol 19:315\u2013322","journal-title":"Curr Opin Oncol"},{"key":"688_CR36","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.bjoms.2007.03.016","volume":"45","author":"P Vescovi","year":"2007","unstructured":"Vescovi P, Merigo E, Meleti M, Fornaini C, Nammour S, Manfredi M (2007) Nd:YAG laser biostimulation of bisphosphonate-associated necrosis of the jawbone with and without surgical treatment. Br J Oral Maxillofac Surg 45:628\u2013632","journal-title":"Br J Oral Maxillofac Surg"},{"key":"688_CR37","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/S0278-2391(03)00328-8","volume":"61","author":"J Wang","year":"2003","unstructured":"Wang J, Goodger NM, Pogrel MA (2003) Osteonecrosis of the jaws associated with cancer chemotherapy. J Oral Maxillofac Surg 61:1104\u20131107","journal-title":"J Oral Maxillofac Surg"},{"key":"688_CR38","doi-asserted-by":"crossref","first-page":"753","DOI":"10.7326\/0003-4819-144-10-200605160-00009","volume":"144","author":"SB Woo","year":"2006","unstructured":"Woo SB, Hellstein JW, Kalmar JR (2006) Narrative [corrected] review: bisphosphonates and osteonecrosis of the jaws. Ann Intern Med 144:753\u2013761","journal-title":"Ann Intern Med"},{"key":"688_CR39","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1002\/hed.20864","volume":"30","author":"A Wutzl","year":"2008","unstructured":"Wutzl A, Biedermann E, Wanschitz F, Seemann R, Klug C, Baumann A, Watzinger F, Schicho K, Ewers R, Millesi G (2008) Treatment results of bisphosphonate-related osteonecrosis of the jaws. Head Neck 30:1224\u20131230","journal-title":"Head Neck"},{"key":"688_CR40","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s00508-006-0644-8","volume":"118","author":"A Wutzl","year":"2006","unstructured":"Wutzl A, Eisenmenger G, Hoffmann M, Czerny C, Moser D, Pietschmann P, Ewers R, Baumann A (2006) Osteonecrosis of the jaws and bisphosphonate treatment in cancer patients. Wien Klin Wochenschr 118:473\u2013478","journal-title":"Wien Klin Wochenschr"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-009-0688-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00520-009-0688-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-009-0688-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T02:01:53Z","timestamp":1559095313000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00520-009-0688-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7,17]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["688"],"URL":"https:\/\/doi.org\/10.1007\/s00520-009-0688-1","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,7,17]]}}}